验证数据展示
发表文章中的应用
WB | See 1 publications below |
IF | See 1 publications below |
产品信息
60182-1-Ig targets SMAD4 in WB, IF, ELISA applications and shows reactivity with human, mouse, rat samples.
Tested Applications | ELISA Application Description |
Cited Applications | WB, IF |
Tested Reactivity | human, mouse, rat |
Cited Reactivity | human |
Immunogen | SMAD4 fusion protein Ag0299 种属同源性预测 |
Host / Isotype | Mouse / IgG2a |
Class | Monoclonal |
Type | Antibody |
Full Name | SMAD family member 4 |
Synonyms | |
Calculated Molecular Weight | 60 kDa |
Observed Molecular Weight | 63 kDa |
GenBank Accession Number | BC002379 |
Gene Symbol | SMAD4 |
Gene ID (NCBI) | 4089 |
Conjugate | Unconjugated |
Form | Liquid |
Purification Method | Protein A purification |
UNIPROT ID | Q13485 |
Storage Buffer | PBS with 0.02% sodium azide and 50% glycerol pH 7.3. |
Storage Conditions | Store at -20°C. Stable for one year after shipment. Aliquoting is unnecessary for -20oC storage. |
背景介绍
Mammalian homologs of the Drosophila Mad gene include Smad1, Smad2, Smad3, Smad4 (DPC4), Smad5, Smad6, Smad7 and Smad8. Smad1 and Smad5 are effectors of BMP2 and BMP4 function while Smad2 and Smad3 are involved in TGF and activin-mediated growth modulation. Smad4 has been shown to mediate all of the above activities through interactionwith various Smad family members . Smad6 and Smad7 regulate the response to activin/ TGF signaling by interfering with TGF -mediated phosphorylation of other Smad family members. This antibody is a mouse monoclonal antibody raised against an internal region of human SMAD4.
实验方案
Product Specific Protocols | |
---|---|
IHC protocol for SMAD4 antibody 60182-1-Ig | Download protocol |
Standard Protocols | |
---|---|
Click here to view our Standard Protocols |
发表文章
Species | Application | Title |
---|---|---|
Photochem Photobiol Sci Downregulation of SMAD4 protects HaCaT cells against UVB-induced damage and oxidative stress through the activation of EMT | ||
Br J Pharmacol Dual targeting chimeric antigen receptor cells enhance antitumour activity by overcoming T cell exhaustion in pancreatic cancer |